HEALTH OPTIONS EUROPE (HOPE ) LTDActive

Company number 08103474Private limited companyIncorporated 2012

Key figures

−£68,846-31.3%
Net assets 2024/25
-80 k-60 k-40 k-20 k020 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, HEALTH OPTIONS EUROPE (HOPE ) LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k150 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets1,0011,00013,188135,7271,186
Total liabilities————70,032
Net assets / total equity-2,670-12,973-26,624-52,446-68,846
Average number of employees11110

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HEALTH OPTIONS EUROPE (HOPE ) LTD

Company

HEALTH OPTIONS EUROPE (HOPE ) LTD is a private limited company registered with Companies House under company number 08103474. It was incorporated on 13 Jun 2012. Its status is active. The registered office is in London (N11). Its nature of business (SIC 2007) is agents involved in the sale of a variety of goods (46190), wholesale of pharmaceutical goods (46460), non-specialised wholesale trade (46900), retail sale via mail order houses or via Internet (47910).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files micro-entity accounts. Net assets were −£68,846, down 31.3% on the previous year. Total assets were £1,186 and total liabilities £70,032. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 3 May 2027.